Clinical Study to Review the Effects of an Auricular and Percutaneous Electric Stimulation of Nervus Vagus on the Oxygen Supply of Skin of Patients With Severe Claudicatio Intermittens

Payrits, Thomas, M.D.2 个研究点分布在 1 个国家目标入组 12 人开始时间: 2014年4月1日最近更新: 2015年3月11日

适应症

试验速览

阶段: 不适用
发起方
入组人数: 12
试验地点: 2
主要终点: change in transcutaneous oxygen partial pressure

研究概览研究设计入排标准结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

H-1: tcpO2U2 > tcpO2U1 H-0: tcpO2U2 ≤ tcpO2U1

研究设计

研究类型: Interventional
分配方式: Na
干预模型: Single Group
主要目的: Prevention
盲法: None

入排标准

年龄范围: 18 Years 至 —（Adult, Older Adult）
性别: All
接受健康志愿者: 否

入选标准

•Each subject must sign an informed consent (ICF) indicating that he or she understands the purpose of and procedures required for the study and are willing to participate in the study.
•PAVK stadium IIb due to Fontaine for at least 6 month
•reduced systolic occlusion pressure at ankle (arteria tibialis posterior and anterior): ABI <0,9
•radiologic significant occlusion at arteria femoralis superficialis and/or at arteria poplitea and/or at arteria of lower legs (MRT, CT, CO2-angiography or color-coded duplex sonography)
•expected availability during study participation over 12 weeks (via health care center)

排除标准

•<18 years 2) pregnancy and non-exclusion of pregnancy (women of child-bearing potential)
•risk of incidence of pregnancy during study participation (female must fulfill one of the following criteria: menopause for more than 2 years, postmenopausal sterilisation, surgical sterilisation, hormonal contrazeption during study participation, spiral or diaphragm/condome+spermicide).
•lactation period 5) person of legal incapacity 6) regard, placement or appointment of an solicitor 7) military service 8) contraindication for the application of STIVAX 8a) malignant tumour (existence of a known, histologic verified, malignant tumour) 8b) hemophilia 8c) psoriasis vulgaris 8d) recent stroke 8e) superficial and deep infection of auricle and external auditory canal 9) (with the exception of STIVAX-application): foreseeable relevant stimulation of afferent contents of vagus to the ear within next 2 weeks.
•isolated diabetic microangiopathia 11) implantated cardiac pacemaker or defibrillator 12) transcutaneous partial pressure of oxygen (tcpO2) > 50 mmHg 13) concomitant disease with potential to limit the significance of the investigation of the walk distance (angina pectoris, heart failure, relevant pulmonary disease, relevant orthopedic or neurologic disease) 14) concomitant disease with potential to improve or to worsen the walking or the perfusion of the extremities in a relevant way.
•foreseeable change of PAVK-relevant medication or of concomitant medication with the potential to improve or to worsen the walking or the perfusion of the extremities in a relevant way within next 2 weeks.
•foreseeable start of a structured walking training within the next 2 weeks. 17) change in PAVK relevant medication or concomitant medication with potential to improve or worsen the walking or the perfusion of the extremities in a relevant way within the last 3 months.
•start with structured walking training within the last 3 months. 19) change in smoking habits within the last 3 months. 20) simultaneous participation in another clinical trial with insurance-protection.
•use of a therapy with stimulation of the afferent parts of vagus on the ear in the past.

结局指标

主要结局

change in transcutaneous oxygen partial pressure

时间窗: 2015

次要结局

changes in SF 36(2015)

研究者

发起方

Payrits, Thomas, M.D.

申办方类型

Indiv

责任方

Sponsor

研究点 (2)

Loading locations...

相似试验

已完成

不适用

A clinical study to evaluate the effects of the indoor plants on recovery from fatigueHealthy volunteers

JPRN-UMIN000035339Soiken Inc.36

已完成

不适用

Evaluating the biological effects of pre-operative intravenous administration of JX-594 (thymidine kinase-deactivated Vaccinia virus plus GM-CSF) prior to planned surgical resection of locally advanced/poor prognosis or metastatic cancers.Cancer

ISRCTN13913966niversity of Leeds40

已完成

1 期

NCT00301938National Cancer Institute (NCI)30

已完成

1 期

Safety and Effectiveness of Combining Hydroxyurea (HU) With Didanosine (ddI) and Stavudine (d4T) for Treatment of HIV-Infected AdultsHIV Infections

NCT00002427Research Institute for Genetic and Human Therapy225

已完成

2 期

Hydroxy Urea, Omega 3, Nigella Sativa,Honey on Oxidative Stress and Iron Chelation in Pediatric Major ThalassemiaIron OverloadOxidative StressThalassemia Major

NCT04292314Beni-Suef University350